Author

Ryan F. Boyd

Charles River Laboratories (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:non-human primate· 1

Frequent Co-Authors

Alexa P. GrayiD· 1 shared Ana Ripolles‐GarciaiD· 1 shared Christopher Kozlowski· 1 shared Diego S. Fajardo· 1 shared Emily M. XuiD· 1 shared Eva Andrés‐Mateos· 1 shared Evelyn SantanaiD· 1 shared Gustavo David AguirreiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alexa P. GrayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preclinical Development and Safety of Laterally Spreading Dual AAV.SPR-MYO7A Vectors for the Treatment of Usher Syndrome Type 1B

Kaitlyn R. Calabro, Eva Andrés‐Mateos, Christopher Kozlowski, Paige S. Nemec, Emily M. Xu, Sean M. Crosson, Diego S. Fajardo, Hannah L. Friend, James J. Peterson, Wei Li, Hangning Zhang, Hugh Lee Sweeney, Victoria A. Stevenson, Howard Rind, Matthew Leahy, , Shannon E. Boye

This paper develops and tests dual AAV vectors for treating USH1B by reconstituting full-length MYO7A expression, showing safety and efficacy in non-human primates.

bioRxiv · Oct 29, 2026 · PreprintGenetics

Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness

Keiko Miyadera, Evelyn Santana, Karolina P. Roszak, Sommer Iffrig, Meike Visel, Simone Iwabe, Ryan F. Boyd, Joshua T. Bartoe, Yu Sato, Alexa P. Gray, Ana Ripolles‐Garcia, Valérie Dufour, Leah C. Byrne, John G. Flannery, William A. Beltran, Gustavo David Aguirre

This paper demonstrates that AAV gene therapy targeting ON-bipolar cells in a canine model of LRIT3-CSNB significantly improves night vision and restores LRIT3 function.

Proceedings of the National Academy of Sciences · Mar 22, 2022Peer-reviewedNeuroscience